Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fluphenazine decanoate
Drug ID BADD_D00936
Description A phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine.
Indications and Usage For management of manifestations of psychotic disorders.
Marketing Status Prescription; Discontinued
ATC Code N05AB02
DrugBank ID DB00623
KEGG ID D00793
MeSH ID C011825
PubChem ID 3388
TTD Drug ID D03NTJ
NDC Product Code 51927-2234; 55150-267; 42023-129; 0143-9529; 67457-359; 71277-0127; 51927-0114; 63323-272; 48954-458; 71052-024; 71277-0125; 69766-073; 67763-123
Synonyms fluphenazine depot | fluphenazine decanoate | ftorphenazine decanoate | mirenil | moditen depot | moditen-depot | liogen | modecate
Chemical Information
Molecular Formula C32H44F3N3O2S
CAS Registry Number 5002-47-1
SMILES CCCCCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diabetes mellitus05.06.01.001; 14.06.01.001--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Dyskinesia17.01.02.006--
Dysphagia07.01.06.003--
Dyspnoea02.01.03.002; 22.02.01.004--
Dystonia17.01.03.001--Not Available
Eczema23.03.04.006--
Embolism venous24.01.01.003--Not Available
Eosinophilia01.02.04.001--
Erythema23.03.06.001--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Extrapyramidal disorder17.01.02.007--
Feeling abnormal08.01.09.014--Not Available
Galactorrhoea21.05.02.002; 05.03.04.002--Not Available
Glaucoma06.03.01.002--
Gynaecomastia21.05.04.003; 05.05.02.003--
Haemolytic anaemia01.06.03.002--Not Available
Headache17.14.01.001--
Hepatic function abnormal09.01.02.001--Not Available
Hepatitis09.01.07.004--Not Available
Hepatocellular injury09.01.07.008--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperreflexia17.02.01.002--Not Available
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hyponatraemia14.05.04.002--
Hypotension24.06.03.002--
The 2th Page    First    Pre   2 3 4 5    Next   Last    Total 5 Pages